carbachol has been researched along with Vibrio cholerae Infection in 5 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cytotoxic action of lymphocytes upon cells bearing alloantigens to which they are sensitized is inhibited by agents that elevate intracellular amounts of 3':5'-cyclic AMP: prostaglandin E(1), cholera toxin, and theophylline." | 3.65 | Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. ( Carpenter, CB; Deisseroth, A; Merrill, JP; Morganroth, J; Strom, TB, 1972) |
| " Increases in the cyclic AMP levels of attacking lymphocytes by stimulation with prostaglandin E(1), isoproterenol, and cholera toxin inhibit lymphocyte-mediated cytotoxicity; whereas, depletion of cyclic AMP with imidazole enhances cytotoxicity." | 3.65 | The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. ( Austen, KF; Carpenter, CB; Garovoy, MR; Kaliner, M; Merrill, JP; Strom, TB, 1973) |
| " Incubation of cells with exogenous cAMP or with agents that increase endogenous cAMP levels (prostaglandin E1, histamine, isoproterenol, and cholera enterotoxin) reduced extrusion of lysosomal enzymes; in contrast, exogenous cGMP and carbamylcholine chloride (which increases endogenous cGMP levels), increased beta-glucuronidase release." | 3.65 | Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. ( Hoffstein, S; Kammerman, S; Tai, HH; Weissmann, G; Zurier, RB, 1974) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaliner, M | 2 |
| Wasserman, SI | 1 |
| Austen, KF | 2 |
| Strom, TB | 2 |
| Deisseroth, A | 1 |
| Morganroth, J | 1 |
| Carpenter, CB | 2 |
| Merrill, JP | 2 |
| Garovoy, MR | 1 |
| Zurier, RB | 1 |
| Weissmann, G | 1 |
| Hoffstein, S | 1 |
| Kammerman, S | 1 |
| Tai, HH | 1 |
| Gale, RP | 1 |
| Zighelboim, J | 1 |
5 other studies available for carbachol and Vibrio cholerae Infection
| Article | Year |
|---|---|
Immunologic release of chemical mediators from human nasal polyps.
Topics: Allergens; Anaphylaxis; Butyrates; Carbachol; Chemotaxis; Cholera; Cyclic AMP; Cystic Fibrosis; Depr | 1973 |
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase.
Topics: Acetylcholine; Adenylyl Cyclases; Animals; Butyrates; Carbachol; Cholera; Cyclic AMP; Enzyme Activat | 1972 |
The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity.
Topics: Animals; Carbachol; Cholera; Cyclic AMP; Cyclic GMP; Cytotoxicity Tests, Immunologic; Graft Rejectio | 1973 |
Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.
Topics: Atropine; Carbachol; Cholera; Colchicine; Cyclic AMP; Cyclic GMP; Cytochalasin B; Deuterium; Enterot | 1974 |
Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity.
Topics: Acetylcholine; Aminophylline; Animals; Antibodies; Carbachol; Cholera; Colchicine; Cyclic AMP; Cycli | 1974 |